This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Quantitative real-time polymerase chain reaction and Western blotting were used to evaluate mRNA and proteinexpression levels. Network pharmacology analysis was conducted to predict potential targets of HMA in HCC. Cell migration and invasion were assessed using wound healing and transwell assays.
For instance, a dataset generated to study proteinexpression in one context might also reveal valuable information about other biological pathways or processes. Additionally, exploratory analyses can be valuable for identifying new biological markers or hypotheses.
We built our proprietary OPERA platform ( here ), leveraging oligonucleotide guided RNA editing to modulate proteinexpression. We intended to learn from nature (genetics) and use pharmaceuticals properties to drive patient benefit. The experiment worked and showed the precision of RNA editing.
Traditional biologics often involve recombinant proteinexpression in mammalian cells or microbes like E. As with any novel approach, Lumen faced challenges in navigating regulatory frameworks for spirulina-based therapeutics. coli and yeast, but spirulina presents a new set of considerations.
One such opportunity, for example, is in proteinexpression. When working with proteins — or designing new ones — scientists must first express them within a cellular “host,” which in turn demands that the proteins be successfully translated and folded into a stable, soluble structure.
The osteoblastic differentiation of human marrow-derived mesenchymal stem cells (hBMSCs) was induced and evaluated by ALP staining and activity assay, Alizarin Red S (ARS) staining, and related proteinexpression analysis. An osteoporotic mouse model was induced by ovariectomy (OVX).
Where vector presence is detected, transgene mRNA and/or proteinexpression levels should also be measured. For cell therapy products, the draft guidance notes that in vivo imaging techniques provide certain advantages. For gene therapy products, the use of quantitative and sensitive assays such as qPCR are recommended.
Making strategic decisions when designing the protocol, such as including biomarkers like programmed death ligand-1 proteinexpression to guide the use of immune checkpoint inhibitors during treatment, can better assure safety and efficacy.
Western blot analysis of rat liver lysates and microsomes confirmed higher rCYP3A1 proteinexpression in untreated SLCO2B1 +/+ compared to Slco2b1 -/ - rats.
We further introduce a comprehensive list of proteins involved in splicing and leverage both cysteine- and protein-directed activity-based protein profiling (ABPP) data with electrophilic scout fragments to demonstrate covalent ligandability for many classes of splicing factors and splicing regulators in primary human T cells.
We further introduce a comprehensive list of proteins involved in splicing and leverage both cysteine- and protein-directed activity-based protein profiling (ABPP) data with electrophilic scout fragments to demonstrate covalent ligandability for many classes of splicing factors and splicing regulators in primary human T cells.
Remimazolam induced PDPK1 and p-AKT proteinexpressions, and suppressed NLRP3 proteinexpression in lung tissue of mice model. In vitro model, Remimazolam also induced PDPK1 and p-AKT proteinexpressions, and suppressed NLRP3 proteinexpression. Remimazolam interlinked PDPK1 protein.
Biochemical kits was utilized for checking the ATP, mitochondrial DNA, MDA, GSH, and Fe 2+ levels in the Huh7 cells, and western blot for measuring the ferroptosis and AMPK/mTOR related-proteinexpression levels.
Western blot analysis was applied to detect the proteinexpression of apoptosis HN1. The effects of matrine on tumor growth, proteinexpression of HN1, and apoptosis in vivo were validated by xenograft tumor models and histology. HN1 overexpression perceptibly reversed the above-mentioned additive effect in vitro.
In an earlier blog article, we discussed the issue of protein aggregation, how to detect it and how we screen solution conditions to overcome it. Many of the other issues with ill-behaved proteins.
The mRNA or proteinexpressions of examined genes were measured by quantitative real-time polymerase chain reaction or Western blot. The viability, migration, and invasion of TC cells were detected by cell counting kit-8, wound healing, and transwell assays.
Sorafenib and glimepiride simultaneously downregulated c-Maf proteinexpression to induce G1 phase arrest and apoptosis in myeloma cells. Moreover, both compounds simultaneously downregulated c-Maf proteinexpression to induce G1 phase arrest and apoptosis in myeloma cells.
OVCAR-3 and SKOV-3 cells were treated with diosgenin, cellular viability was assessed by MTT assay and apoptosis was measured by ELISA and evaluated the proteinexpression levels of apoptotic markers through western blotting. The proteinexpression levels of main components of PI3K signaling were evaluated via western blotting.
The results showed that hsa-miR-503-5p showed high expression, while its target gene CTDSPL presented decreased expression in LUAD. Hsa-miR-503-5p also had high expression in cisplatin-resistant LUAD cells. Binding relationship between the two genes was verified by dual-luciferase reporter assay.
Inflammatory factors in the serum were measured using ELISA assays, immunohistochemistry and qRT-PCR were performed to determine macrophage numbers and the expression of iNOS, CD86, Arg-1, and Mrc1 in myocardial tissue. The proteinexpression levels of TLR4, Myd88, and NF-κB in myocardial tissue were assessed through western blot analysis.
The proteinexpression levels of nuclear factor-erythroid 2-related factor 2 (Nrf2), matrix metalloproteinase (MMP)-2, and MMP-9 were detected by western blotting. Besides, the decreased Nrf2 expression reduced the proteinexpression levels of MMP-2 and MMP-9 ( p < .05).
Western blotting was utilized for proteinexpression and epigenetic studies utilized chromatin immunoprecipitation methods. Furthermore, KET restored acetylated histone occupancy at the Bdnf promoter IV and induced BDNF proteinexpression in DFP rats. mg/kg s.c., At 6-m following DFP exposure, KET (10 mg/kg, i.p.)
At the same time, CBG and EAA did not modify the expression/structure of proteins in relation to the non-irradiated control keratinocytes in the case of an unaccompanied use, or slightly modified the protein profile when used in a mixture.
Western blot and molecular docking indicated that compound 22 may exert antioxidant activity by activating Nrf2 proteinexpression. This might be due to the introduction of 2, 5-difluorobenzene sulfonate group in PF, which helps in scavenging free radicals under oxidative stress.
SIRT1 expression was enhanced by Icariin, and its knockdown suppressed Icariin-induced BMSC osteogenic differentiation. Moreover, deubiquitinating enzyme USP47 could stabilize SIRT1 proteinexpression.
The results showed that CA-COS inhibited nitric oxide (NO) production and downregulated the gene expression of nitric oxide synthase (iNOS), and cytokines such as tumor necrosis factor-alpha (TNF-α), IL-1β, and IL-6 without cytotoxic effect.
We hypothesized that ligustrazine could protect liver by decreasing the inflammation response, protein production, and apoptosis in THS rats. The proteinexpressions were detected via western blot. Ligustrazine at doses of 100 and 1000 μg/mL was administrated in Kupffer cells isolated from THS rats.
Further, the study detected the effect of SA on cell apoptosis, lipid peroxidation, Fe 2+ level, and ferroptosis-related proteinsexpression. Finally, the effect of HMGB1 expression on SA in H/R stimulation was studied.
Linagliptin administered to the type 1 diabetic mouse heart significantly reduced the expression levels of the total and cleaved forms of ATF6, ATF4, and p-JNK, caspase 3. According to ELISA findings, TUDCA was more effective in reducing NOX 1 and MDA levels than linagliptin.
The mRNA and proteinexpression levels of p53, p-glycoprotein (P-gp), ATM, ATR, CHK1, and CHK2 were assessed through qRT-PCR and western blotting. OECM-1 and OECM-1/PTX were transfected with miR-34 mimic and inhibitor. Cellular proliferation and apoptosis were evaluated through MTT assay and flow cytometry, respectively.
RT-qPCR and western blotting were used to test the mRNA and proteinexpression levels of IL-17 and retinoid-related orphan receptor-γt (RORγt). PGE2 was highly expressed in the DE mouse model. The mRNA and protein levels of IL-17 and the key Th17 transcription factor RORγt were increased in tissues of the DE mice.
Colonic pathological changes were analyzed by hematoxylin–eosin staining, and inflammatory factor expressions in serum were determined by enzyme-linked immunosorbent assay. Immunohistochemistry and western blot were performed to quantify ferroptosis-related proteinexpressions.
Hederagenin attenuated HG-induced increase in mRNA and proteinexpression of NLRP3, ASC, and IL-1β. The secretion levels of fibrosis-related biomarkers were analyzed by ELISA. Results showed that hederagenin reduced HG-induced proliferation increase in HRMCs and HRPTEpiCs. IV, PAI-1, and TGF-β1.
In addition, SAS treatment caused a significant decrease in the mRNA and proteinexpression of xCT and GPX4, and a significant increase in ACSL4 expression in TE-1 cells treated with SAS. Flow cytometry results showed that the ferroptosis level was significantly increased after SAS treatment.
A label-free proteomics technology was employed to investigate alterations in proteinexpression in LoVo cells treated with plumbagin. Cell cycle analysis and cell apoptosis analysis were conducted to break down the anticancer impact of plumbagin on LoVo cells.
Also, Vinp downregulated α-Syn proteinexpression and MDA level, while upregulated SOD activity in the striatum of PD rats. Vinp treatment increased the horizontal movement frequency and number of squares crossed, reduced the contact time, and rotation frequency in PD rats.
The mRNA or proteinexpressions of examined genes in microglia and brain tissues were detected by quantitative real-time polymerase chain reaction or western blot.
BoNT/A (1 nM) attenuated LPS/ATP-stimulated inhibition of viability and CAMP expression and upregulation of inflammatory mediators, pyroptosis-related proteins, and ELANE expression in rat DRG neurons, which was counteracted by CAMP silencing.
Elisa's result showed that CQQNC can significantly decrease the expression levels of cPLA2, sPLA2, PGE2, cAMP, and 15-PGDH after stimulating IL-1β to bEnd.3 3 cells in a dose-dependent manner ( p < .01, 01, p < .001, 001, p < .0001). 3 ( p < .0001, 0001, p < .001, 001, p < .01).
The expression of miR-181a-3p was inhibited; however, SHQ1 expression was increased by β-sitosterol treatment of A549/anlotinib cells. The inhibition of SHQ1, ATF6, and GRP78 proteinexpression by β-sitosterol in A549/anlotinib cells was rescued by increased miR-181a-3p.
In the analysis of network pharmacology, 269 pharmacological targets of SP, 449 pharmacological targets of FC, and 2569 targets of HS-related diseases were screened from the databases.
Predictive models for biology will span all scales, from individual proteins to the culture conditions in which cells grow. Large-scale experiments suggest that <50% of bacterial proteins and <15% of non-bacterial proteinsexpress within E. coli , yeast, and other types of organisms.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content